These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 36233225)
1. Spontaneous Occurrence of Various Types of Hepatocellular Adenoma in the Livers of Metabolic Syndrome-Associated Steatohepatitis Model TSOD Mice. Shao W; Jargalsaikhan O; Ichimura-Shimizu M; Cai Q; Ogawa H; Miyakami Y; Atsumi K; Tomita M; Sutoh M; Toyohara S; Hokao R; Kudo Y; Oya T; Tsuneyama K Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233225 [TBL] [Abstract][Full Text] [Related]
2. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863 [TBL] [Abstract][Full Text] [Related]
3. Tsumura-Suzuki obese diabetic mice-derived hepatic tumors closely resemble human hepatocellular carcinomas in metabolism-related genes expression and bile acid accumulation. Takahashi T; Deuschle U; Taira S; Nishida T; Fujimoto M; Hijikata T; Tsuneyama K Hepatol Int; 2018 May; 12(3):254-261. PubMed ID: 29651702 [TBL] [Abstract][Full Text] [Related]
4. Histopathological characteristics of glutamine synthetase-positive hepatic tumor lesions in a mouse model of spontaneous metabolic syndrome (TSOD mouse). Takahashi T; Nishida T; Baba H; Hatta H; Imura J; Sutoh M; Toyohara S; Hokao R; Watanabe S; Ogawa H; Uehara H; Tsuneyama K Mol Clin Oncol; 2016 Aug; 5(2):267-270. PubMed ID: 27446562 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Shafizadeh N; Genrich G; Ferrell L; Kakar S Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201 [TBL] [Abstract][Full Text] [Related]
6. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders. Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687 [TBL] [Abstract][Full Text] [Related]
9. Hepatocellular Adenoma in an Infant With Burn-McKeown Syndrome: Report of a Case. González IA; Surrey LF; Russo P Pediatr Dev Pathol; 2022; 25(6):668-671. PubMed ID: 36262073 [TBL] [Abstract][Full Text] [Related]
10. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice. Larson BK; Guindi M Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207 [TBL] [Abstract][Full Text] [Related]
11. Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. Nishida T; Tsuneyama K; Fujimoto M; Nomoto K; Hayashi S; Miwa S; Nakajima T; Nakanishi Y; Sasaki Y; Suzuki W; Iizuka S; Nagata M; Shimada T; Aburada M; Shimada Y; Imura J Lab Invest; 2013 Feb; 93(2):230-41. PubMed ID: 23212097 [TBL] [Abstract][Full Text] [Related]
12. Verification of the Impact of Blood Glucose Level on Liver Carcinogenesis and the Efficacy of a Dietary Intervention in a Spontaneous Metabolic Syndrome Model. Ichimura-Shimizu M; Kageyama T; Oya T; Ogawa H; Matsumoto M; Sumida S; Kakimoto T; Miyakami Y; Nagatomo R; Inoue K; Cheng C; Tsuneyama K Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884650 [TBL] [Abstract][Full Text] [Related]
14. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas. Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349 [TBL] [Abstract][Full Text] [Related]
16. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669 [TBL] [Abstract][Full Text] [Related]
17. Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Bioulac-Sage P; Cubel G; Balabaud C; Zucman-Rossi J Semin Liver Dis; 2011 Feb; 31(1):91-103. PubMed ID: 21344354 [TBL] [Abstract][Full Text] [Related]
18. Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice. Watanabe S; Takahashi T; Ogawa H; Uehara H; Tsunematsu T; Baba H; Morimoto Y; Tsuneyama K Metab Syndr Relat Disord; 2017 May; 15(4):170-177. PubMed ID: 28358620 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma. Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]